We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
+94.34%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$3.44B
AUM Growth
+$1.31B
Cap. Flow
-$550M
Cap. Flow %
-15.98%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
3
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
+$20.4M
2
AXLA
Axcella Health Inc. Common Stock
AXLA
+$18.6M
3
KLDO
Kaleido Biosciences, Inc. Common Stock
KLDO
+$13.4M

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$602M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$2.56B 74.39%
39,871,524
-11,000,000
-22% -$602M
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
$229M 6.65%
38,296,526
– –
DNLI icon
3
Denali Therapeutics
DNLI
$3.67B
$193M 5.61%
7,980,263
– –
KLDO
4
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$144M 4.18%
19,360,710
+2,000,000
+12% +$13.4M
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$112M 3.26%
1,145,003
+233,333
+26% +$20.4M
MCRB icon
6
Seres Therapeutics
MCRB
$48.1M
$103M 2.98%
1,078,588
– –
AXLA
7
DELISTED
Axcella Health Inc. Common Stock
AXLA
$69.4M 2.02%
501,937
+152,000
+43% +$18.6M
SYRS
8
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$31.3M 0.91%
293,849
– –

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q2 2020 Portfolio in Review

As of Q2 2020, Flagship Pioneering held 8 positions worth $3.44B, up 61% from $2.13B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering withdrew a net $550M in Q2 2020, reducing 1 holding. Its largest reduction was Moderna, cutting an estimated $602M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Flagship Pioneering added an estimated $20.4M to Evelo Biosciences, Inc. Common Stock.

  • Flagship Pioneering added most to Evelo Biosciences, Inc. Common Stock in Q2 2020, an estimated $20.4M increase.
  • Flagship Pioneering's biggest Q2 2020 reduction was Moderna, cutting an estimated $602M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $3.44B portfolio in Q2 2020.
  • Flagship Pioneering opened 0 new positions and closed 0 in Q2 2020.
  • Flagship Pioneering's portfolio value rose 61% quarter-over-quarter to $3.44B.

Based on Flagship Pioneering's 13F filing for Q2 2020, filed 13 Aug 2020.